This resource is part of our Treatment Navigator, a comprehensive guide to common behavioral/mental health diagnoses and the evidence based practices (EBPs) that help these conditions.

Overview

Gender Dysphoria refers to the clinically significant distress or impairment that arises from an incongruence between an individual’s experienced or expressed gender and the sex assigned at birth. This distress may manifest as anxiety, depression, social withdrawal, or body-related discomfort, particularly when social or physical transition is hindered by external barriers or internal conflict. The focus of treatment is not on changing one’s gender identity, but on alleviating distress, supporting identity integration, and facilitating authentic, self-directed decisions regarding social, medical, or legal transition.

Indicated Evidence-Based Practices (EBPs)

• Gender-Affirming Psychotherapy – client-centered approach emphasizing exploration, validation, and support in identity development and transition planning
• Cognitive Behavioral Therapy (CBT) – addresses anxiety, depression, or negative self-beliefs related to minority stress or dysphoria
• Acceptance and Commitment Therapy (ACT) – promotes self-acceptance, psychological flexibility, and values-guided action amid societal stressors
• Interpersonal Psychotherapy (IPT) – focuses on relational challenges, identity disclosure, and social role transitions
• Family-Based Interventions – provide education, reduce rejection, and enhance support, particularly for adolescents
• Collaborative Multidisciplinary Care – coordinates psychotherapy with medical and social supports, including endocrinology, primary care, and community resources

When to Choose What

Gender-affirming psychotherapy forms the foundation of all evidence-based care for gender dysphoria.

CBT and ACT are indicated for clients experiencing co-occurring anxiety, depression, or internalized stigma.

Family-based approaches are essential for adolescents, as caregiver acceptance strongly predicts mental health outcomes.

IPT may be useful for clients navigating disclosure, family or partner conflict, or relational stress during transition.

Collaboration with medical providers is appropriate when the client is exploring or pursuing gender-affirming hormone therapy or surgeries.

Therapy should remain exploratory and supportive, avoiding coercive or directive approaches regarding identity or transition decisions.

Core Components of Treatment

• Psychoeducation on gender diversity, dysphoria, and minority stress
• Exploration of gender identity, expression, and lived experience in a safe therapeutic space
• Cognitive restructuring to address shame, internalized transphobia, or negative self-perceptions
• Emotion regulation and mindfulness skills for managing dysphoria-related distress
• Values-based goal setting for social, relational, and medical transitions (if desired)
• Safety planning for clients facing discrimination, housing instability, or suicidal ideation
• Family and partner involvement when appropriate to foster understanding and support
• Advocacy and linkage to affirming community resources

Measures and Monitoring

Screening and diagnostic tools

• Gender Identity/Gender Dysphoria Questionnaire for Adolescents and Adults (GIDYQ-AA): measures intensity and impact of dysphoria
• Utrecht Gender Dysphoria Scale (UGDS): assesses discomfort related to assigned gender characteristics and social gender role
• Gender Minority Stress and Resilience Measure (GMSR): evaluates minority stress, internalized stigma, and coping factors
• PHQ-9 and GAD-7: track co-occurring depressive and anxiety symptoms
• Columbia-Suicide Severity Rating Scale (C-SSRS): recommended for assessing suicide risk, given elevated rates among gender-diverse individuals

Monitoring and outcome tools

• PHQ-9, GAD-7, or GMSR every 4–6 sessions to assess emotional wellbeing and stress
• SRS (Session Rating Scale) to monitor alliance and sense of affirmation
• Client-defined quality of life indicators (e.g., comfort in public settings, social connection, authenticity at work or school)
• Regular interdisciplinary review when integrated with medical transition care

Adaptations and Special Considerations

Affirmative stance: Therapists must provide a validating environment that affirms the client’s gender identity and lived experience. Therapy should never pathologize identity diversity.

Adolescents: Involve caregivers and coordinate with medical teams following established guidelines (e.g., WPATH, AACAP). Emphasize family education, support, and advocacy.

Cultural context: Explore how cultural, faith, or community factors shape gender expression and acceptance.

Trauma and minority stress: Address experiences of discrimination, violence, or rejection using trauma-informed care principles.

Comorbidity: Treat co-occurring depression, anxiety, or trauma without attributing all distress solely to gender dysphoria.

Telehealth: Particularly valuable for clients in areas lacking affirming providers; ensure privacy and access to resources.

References

American Psychiatric Association. (2022). Diagnostic and Statistical Manual of Mental Disorders (5th ed., text rev.).

World Professional Association for Transgender Health (WPATH). (2022). Standards of Care for the Health of Transgender and Gender Diverse People, Version 8.

American Psychological Association. (2015). Guidelines for Psychological Practice with Transgender and Gender Nonconforming People. American Psychologist, 70(9), 832–864.

Austin, A., & Craig, S. L. (2015). Empirically supported interventions for sexual and gender minority youth: An evidence-informed framework. Journal of Clinical Child & Adolescent Psychology, 44(6), 895–908.

Pachankis, J. E. (2015). A transdiagnostic minority stress treatment approach for gay and bisexual men’s syndemic health conditions. Archives of Sexual Behavior, 44(7), 1843–1860.

Craig, S. L., McInroy, L., & Austin, A. (2021). Affirmative cognitive-behavioral therapy with transgender and gender diverse youth: Adaptation and implementation. Clinical Child Psychology and Psychiatry, 26(4), 1012–1024.